Antiangiogenic therapy in cancer: a new era has begun.

Axel F Grothey

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)5-6
Number of pages2
JournalOncology (Williston Park, N.Y.)
Volume19
Issue number4 Suppl 3
StatePublished - Apr 2005
Externally publishedYes

Fingerprint

Angiogenesis Inhibitors
Medical Oncology
Drug Delivery Systems
Vascular Endothelial Growth Factor A
Monoclonal Antibodies
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Antiangiogenic therapy in cancer : a new era has begun. / Grothey, Axel F.

In: Oncology (Williston Park, N.Y.), Vol. 19, No. 4 Suppl 3, 04.2005, p. 5-6.

Research output: Contribution to journalArticle

Grothey, Axel F. / Antiangiogenic therapy in cancer : a new era has begun. In: Oncology (Williston Park, N.Y.). 2005 ; Vol. 19, No. 4 Suppl 3. pp. 5-6.
@article{b15949b4d742460c81f5d20d5d263944,
title = "Antiangiogenic therapy in cancer: a new era has begun.",
author = "Grothey, {Axel F}",
year = "2005",
month = "4",
language = "English (US)",
volume = "19",
pages = "5--6",
journal = "Oncology",
issn = "0030-2414",
publisher = "UBM Medica Healthcare Publications",
number = "4 Suppl 3",

}

TY - JOUR

T1 - Antiangiogenic therapy in cancer

T2 - a new era has begun.

AU - Grothey, Axel F

PY - 2005/4

Y1 - 2005/4

UR - http://www.scopus.com/inward/record.url?scp=23444433780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23444433780&partnerID=8YFLogxK

M3 - Article

C2 - 16100843

AN - SCOPUS:23444433780

VL - 19

SP - 5

EP - 6

JO - Oncology

JF - Oncology

SN - 0030-2414

IS - 4 Suppl 3

ER -